Financial Instruments and Fair Value Measurements (Schedules of Concentration of Risk) (Details)	3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended			12 Months Ended	6 Months Ended	12 Months Ended	6 Months Ended	12 Months Ended	3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended
	Mar. 28, 2014 Distributor Concentration Risk Net Sales Attributable to Distributors Cardinal Health, Inc.	Mar. 29, 2013 Distributor Concentration Risk Net Sales Attributable to Distributors Cardinal Health, Inc.	Mar. 28, 2014 Distributor Concentration Risk Net Sales Attributable to Distributors Cardinal Health, Inc.	Mar. 29, 2013 Distributor Concentration Risk Net Sales Attributable to Distributors Cardinal Health, Inc.	Mar. 28, 2014 Distributor Concentration Risk Net Sales Attributable to Distributors McKesson Corporation	Mar. 29, 2013 Distributor Concentration Risk Net Sales Attributable to Distributors McKesson Corporation	Mar. 28, 2014 Distributor Concentration Risk Net Sales Attributable to Distributors McKesson Corporation	Mar. 29, 2013 Distributor Concentration Risk Net Sales Attributable to Distributors McKesson Corporation	Mar. 28, 2014 Distributor Concentration Risk Net Sales Attributable to Distributors Amerisource Bergen Corporation	Mar. 29, 2013 Distributor Concentration Risk Net Sales Attributable to Distributors Amerisource Bergen Corporation	Mar. 28, 2014 Distributor Concentration Risk Net Sales Attributable to Distributors Amerisource Bergen Corporation	Mar. 29, 2013 Distributor Concentration Risk Net Sales Attributable to Distributors Amerisource Bergen Corporation	Mar. 28, 2014 Distributor Concentration Risk Accounts Receivable Attributable to Distributors Cardinal Health, Inc.	Sep. 27, 2013 Distributor Concentration Risk Accounts Receivable Attributable to Distributors Cardinal Health, Inc.	Mar. 28, 2014 Distributor Concentration Risk Accounts Receivable Attributable to Distributors McKesson Corporation	Sep. 27, 2013 Distributor Concentration Risk Accounts Receivable Attributable to Distributors McKesson Corporation	Mar. 28, 2014 Distributor Concentration Risk Accounts Receivable Attributable to Distributors Amerisource Bergen Corporation	Sep. 27, 2013 Distributor Concentration Risk Accounts Receivable Attributable to Distributors Amerisource Bergen Corporation	Mar. 28, 2014 Product Concentration Risk Net Sales Attributable to Products Optiray (CMDS)	Mar. 29, 2013 Product Concentration Risk Net Sales Attributable to Products Optiray (CMDS)	Mar. 28, 2014 Product Concentration Risk Net Sales Attributable to Products Optiray (CMDS)	Mar. 29, 2013 Product Concentration Risk Net Sales Attributable to Products Optiray (CMDS)	Mar. 28, 2014 Product Concentration Risk Net Sales Attributable to Products Acetaminophen Products (API) [Member]	Mar. 29, 2013 Product Concentration Risk Net Sales Attributable to Products Acetaminophen Products (API) [Member]	Mar. 28, 2014 Product Concentration Risk Net Sales Attributable to Products Acetaminophen Products (API) [Member]	Mar. 29, 2013 Product Concentration Risk Net Sales Attributable to Products Acetaminophen Products (API) [Member]	Mar. 28, 2014 Product Concentration Risk Net Sales Attributable to Products Methylphenidate ER (Specialty Generics)	Mar. 29, 2013 Product Concentration Risk Net Sales Attributable to Products Methylphenidate ER (Specialty Generics)	Mar. 28, 2014 Product Concentration Risk Net Sales Attributable to Products Methylphenidate ER (Specialty Generics)	Mar. 29, 2013 Product Concentration Risk Net Sales Attributable to Products Methylphenidate ER (Specialty Generics)
Concentration Risk [Line Items]
Concentration risk, percentage	15.00%	20.00%	18.00%	20.00%	15.00%	19.00%	15.00%	16.00%	10.00%	6.00%	11.00%	7.00%	20.00%	18.00%	23.00%	22.00%	13.00%	14.00%	13.00%	13.00%	13.00%	14.00%	9.00%	10.00%	8.00%	10.00%	8.00%	11.00%	9.00%	7.00%